We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Thermo Fisher Scientific Acquires Micro-Volume UV-Vis Instrumentation

By HospiMedica staff writers
Posted on 29 Oct 2007
Thermo Fisher Scientific, Inc. More...
(Waltham, MA, USA) has acquired NanoDrop Technologies, LLC (Wilmington, DE, USA), a manufacturer of microvolume ultraviolet visible (UV-Vis) instrumentation.

The acquisition will strengthen Thermo Fisher's range of UV-Vis spectrophotometry instruments for applications involving small sample volumes. For example, micro-volume samples are used in emerging life sciences research that involves measurement of DNA and proteins. NanoDrop, has annual revenues of approximately US$35 million.

"Growing demand from our laboratory customers to accelerate sample preparation time is now compounded by the need to work with smaller sample sizes,” said Marijn E. Dekkers, president and CEO of Thermo Fisher Scientific. "NanoDrop's patented technologies uniquely allow customers to quickly and easily analyze difficult microvolume samples without the need for dilution. This preserves precious samples to greatly increase laboratory productivity.”

NanoDrop currently produces three products--the NanoDrop ND-1000 and ND-8000 UV-Vis spectrophotometers and the NanoDrop ND-3300 fluorescence spectrophotometer. The ND-1000 is a full-spectrum UV-Vis spectrophotometer used to quantify nucleic acids, proteins, fluorescent dyes, and other compounds. The ND-8000 is also a full-spectrum UV-Vis spectrophotometer that can measure eight samples at a time, permitting measurement of 96 samples in five minutes. The ND-3300 is a versatile fluorometer with broad excitation range that enables the use of microreactions for quantitation of limited mass. These instruments are highly versatile tools that are suitable for a wide variety of laboratories and uses, including life-sciences research and industrial applications.

The NanoDrop product line will be integrated into Thermo Fisher's scientific instruments business, part of its Analytical Technologies Segment, and will be marketed under the company's Thermo Scientific technology brand.


Related Links:
Thermo Fisher Scientific Inc
NanoDrop Technologies

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Autoclave
Advance
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.